Ionis Pharma (IONS): CARDIO-TTR Trial Uncertainty as GSK Stops Initiation - BMO
Tweet Send to a Friend
BMO Capital Markets analyst, Do Kim, notes that Ionis Pharmaceuticals (NASDAQ: IONS) partner GSK will not initiate the CARDIO-TTR Phase ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
